Edimer Secures $18M Series B Financing Led by New Enterprise Associates Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia , today announced it has secured $18 million in Series B financing.
July 30, 2013 - Business Wire via Yahoo! Finance